BSE filing, NSE: LEMONTREE. Summary written from the filing by ALFA Finder's alert engine.
Lemon Tree Hotels Ltd: key numbers
- Share price
- ₹107.15
- Market cap
- ₹8,489 Cr
- Revenue (annual)
- ₹1,444 Cr
- Net profit (annual)
- ₹227.1 Cr
- P/E (TTM)
- 36.1×Sector 43.4×
- Promoter holding
- 22.32%+0.00% QoQ
- FII holding
- 18.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lemon Tree Hotels Ltd
All →Lemon Tree Hotels Capacity Expansion
Lemon Tree Hotels signed a licence agreement for a 63-room Keys Lite hotel in Bhilwara. The subsidiary-managed property expands its Rajasthan footprint; no value disclosed.
- hotel rooms
- 63.0 rooms
Lemon Tree Hotels Other Announcement
Lemon Tree Hotels Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This report details the company's equity distribution across various shareholder categories.
Lemon Tree Hotels Legal & Regulatory
Lemon Tree Hotels reported that the First Appellate Authority has partially allowed its subsidiary Fleur Hotels' appeal against a GST demand order. No material financial impact.
Lemon Tree Hotels Partnership
Lemon Tree Hotels signed an MoU with Omaxe Limited to operate approximately 4,000 hotel keys across India. This represents the company's largest single operating arrangement to date.
- From
- Omaxe Limited
- hotel keys
- 4000.0 keys
Lemon Tree Hotels Capacity Expansion
Lemon Tree Hotels signed a franchise agreement for a new hotel in Bareilly, Uttar Pradesh. The property will feature 52 rooms, expanding the company's network.
- hotel capacity
- 52.0 rooms
Lemon Tree Hotels Employee Stock Options
Lemon Tree Hotels amended its ESOP trust deed, modifying the list of trustees and granting them additional operational powers.
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.